Prolgolimab
Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma[1].
Product Specifications
CAS Number
2093956-19-3
Product Name Alternative
BCD-100
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/prolgolimab.html
Purity
99.15
Solubility
H2O
Smiles
[Prolgolimab]
Molecular Weight
(146.28 kDa)
References & Citations
[1]Tjulandin S, et, al. Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice. Eur J Cancer. 2021 May;149:222-232.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSV030361 100 µg
Recombinant SARS-CoV-2 Spike S1 (K417N, E484K, N501Y, D614G) (His Tag)
Sign In for Pricing
View Details